G1 Therapeutics rises on Q4 revenue beat

G1 Therapeutics

28/02/2024 15:39

** Shares of drugmaker G1 Therapeutics  GTHX.O  rise 17.9%
to $2.82
    ** Co reports Q4 revenue of $14.87 mln, beating analysts'
estimates of $13.07 mln- LSEG data 
    ** Reports narrower Q4 net loss of 21 cents per share,
compared to 73 cents in the year ago quarter 
    ** Believes its current cash runway is sufficient to fund
its operations into 2025- GTHX
    ** Co had cash, cash equivalents and marketable securities
of $82.16 mln as of Dec. 31, 2023 
    ** Including sessions gains, stock has fallen 22.9% in the
last 12 months 

 (Reporting by Sneha S K)
 ((Sneha.SK@thomsonreuters.com;))